Agitation process for preparing a carbetocin drug product Grant US-11844764-B2 United States of America 19 Dec 2023
Anti-neurodegenerative therapeutic, method of manufacture, and use Grant US-11833185-B2 United States of America 05 Dec 2023
BREATH-POWERED NASAL DEVICES FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), INCLUDING… Application WO-2023069126-A1 World Intellectual Property Organisation (WIPO) 27 Apr 2023
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and… Grant US-11497739-B2 United States of America 15 Nov 2022
Carbetocin drug product and process for preparing same Grant US-11298399-B2 United States of America 12 Apr 2022
C3A receptor agonists for use against ischemic brain injury, stroke, traumatic brain… Grant US-11266715-B2 United States of America 08 Mar 2022
Combination of cotinine plus antioxidant for treatment-resistant depression and… Grant US-11260050-B2 United States of America 01 Mar 2022
Agitation process for preparing a carbetocin drug product Grant US-11207373-B2 United States of America 28 Dec 2021
Methods of treating prader-willi syndrome with carbetocin Grant US-10967040-B2 United States of America 06 Apr 2021
Method for endoscopically delivering stem cells to the brain using an intranasal… Application US-10335435-B2 United States of America 02 Jul 2019
ANTI-NEURODEGENERATIVE THERAPEUTIC, METHOD OF MANUFACTURE, AND USE Application WO-2019033099-A1 World Intellectual Property Organisation (WIPO) 14 Feb 2019
C3A RECEPTOR AGONISTS FOR USE AGAINST ISCHEMIC BRAIN INJURY, STROKE, TRAUMATIC BRAIN… Application WO-2018091715-A1 World Intellectual Property Organisation (WIPO) 24 May 2018